Thomas Abbott

Thomas Abbott

Astellas Pharma Inc - Tokyo / Japan
Economics & Econometrics / Economics
AD Scientific Index ID: 4407421
アステラス製薬株式会社
person_outline Thomas Abbott's MOST POPULAR ARTICLES
1-) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesisCM Klotzbuecher, PD Ross, PB Landsman, TA Abbott III, M BergerJournal of bone and mineral research 15 (4), 721-739, 200023802000
2-) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk AssessmentES Siris, PD Miller, E Barrett-Connor, KG Faulkner, LE Wehren, TA Abbott, ...Jama 286 (22), 2815-2822, 200116112001
3-) Bone mineral density thresholds for pharmacological intervention to prevent fracturesES Siris, YT Chen, TA Abbott, E Barrett-Connor, PD Miller, LE Wehren, ...Archives of internal medicine 164 (10), 1108-1112, 200411952004
4-) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databasesES Siris, ST Harris, CJ Rosen, CE Barr, JN Arvesen, TA Abbott, ...Mayo Clinic Proceedings 81 (8), 1013-1022, 20068882006
5-) Osteoporosis and fracture risk in women of different ethnic groupsE Barrett‐Connor, ES Siris, LE Wehren, PD Miller, TA Abbott, ML Berger, ...Journal of bone and mineral research 20 (2), 185-194, 20056562005